Remote magnetic switch off microgate for nanofluidic drug delivery implants

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Drug Delivery Systems

Background:

• Implantable drug delivery devices offer localized or systemic administration for various pathologies.
• Current systems lack effective intervention methods for adverse reactions or dosage adjustments, often requiring surgical retrieval.
• Surgical retrieval is time-sensitive, costly, and necessitates specialized medical facilities.

Purpose of the Study:

• To demonstrate a novel microsystem for rapid and controllable shut-off of drug delivery from implantable nanofluidic systems.
• To provide a non-invasive method for intervention in implantable drug delivery systems.
• To establish a proof of concept for remote titration and interruption of drug administration.

Main Methods:

• Development of a novel microsystem integrated into an implantable nanofluidic device.
• Application of a safe, external electromagnetic field (within FDA-approved dose range) to control drug release.
• In vitro and ex vivo testing to validate the system's functionality.

Main Results:

• Successful demonstration of rapid and effective switch-off of drug delivery.
• Validation of the microsystem's performance in in vitro and ex vivo settings.
• Confirmation that the electromagnetic field is within safe, FDA-approved dosage limits.

Conclusions:

• The developed microsystem offers a novel solution for immediate cessation of drug delivery from implants.
• This technology provides a non-surgical, remotely controlled intervention for implantable drug delivery systems.
• The proof-of-concept has broad applicability for reservoir-based implants, enabling complete interruption or remote titration of drug administration.